LANSING, MI — July 12, 2018 — PRESS RELEASE — The State of Michigan Medical Marihuana Licensing Board unanimously voted to pre-qualify Lansing-based Green Peak Innovations (GPI) for large scale medical cannabis licenses for cultivation, processing and provisioning centers (retail). The pre-qualification by the LARA Bureau of Medical Marihuana Regulation includes 12 class C cultivation licenses, one processor license and 19 provisioning center licenses.
“We are honored that our company was approved by the state’s rigorous licensing process to operate a professional medical cannabis company in Michigan,” said GPI CEO Jeff Radway. “Our team is a diverse group of professionals united behind one simple goal: to create a premium seed-to-store operation in Michigan that patients can trust to consistently supply the highest quality medical cannabis products.”
GPI is currently under construction on its main headquarters and production facility located on 25 acres in Harvest Park, a medical cannabis industrial park in Windsor Township, and an R&D facility in Lansing, with both facilities scheduled for completion late summer. Additionally, GPI owns several properties for provisioning center locations that will launch late 2018 and is acquiring more property throughout Michigan to deploy its pre-qualified provisioning center licenses.
In its first year of business, GPI plans to add up to 200 new jobs across its licensed facilities currently under construction in Michigan. “We are thrilled to be a part of this emerging industry and to contribute to the ongoing growth of the state’s economy,” says Radway. “GPI plans to offer excellent salaries and benefits to high-caliber individuals who are passionate about serving the needs of Michigan’s patients through a career in the cannabis industry.”
The company is preparing for final inspection of its facilities by the LARA Bureau of Medical Marihuana Regulation and anticipates full licensure by the Medical Marihuana Licensing Board in Fall 2018. “We appreciate the diligent process established by LARA to thoroughly vet applicants and arrive at the safest solutions for Michigan’s patients,” says Radway. “We look forward to continuing to work collaboratively with regulators and communities throughout the state.”
